x

Posted 13 September, 2022

Boon Industries, Inc. appointed William J. Reed as new CEO

OTC:BNOW appointed new Chief Executive Officer William J. Reed in a 8-K filed on 13 September, 2022.


  On September 7, 2022, the Board of Directors of the Company appointed William J. Reed to serve as the Chairman of the Board of the Company and as its Chief Executive Officer, President and Secretary.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Boon Industries, Inc.
None • None
CuraScientific Corp. is a bioscience company, which engages in the manufacture of commercial chemical products with applications in commercial sterilization for agriculture, warehousing, hospitality, and medical facilities. The company is headquartered in Coachella, CA.
Market Cap
$377K
View Company Details
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


Resignations of Directors and Officers


On August 3, 2022, Edouard Beaudette submitted a letter of resignation to Boon Industries, Inc. (the “Company”), resigning as a director of the Company and as its Chief Strategic Officer, effective September 3, 2022.


On September 7, 2022, Eric Watson resigned from his positions as a director of the Company and as its Chief Operating Officer; Johann Loewen resigned from his position as a director of the Company; and Justin Gonzalez resigned from his positions as the Company's Chief Executive Officer, President and Secretary. Mr. Gonzalez will continue to serve as a director of the Company, and has been appointed to serve as the Company's Chief Operating Officer.


In connection with his appointment as Chief Operating Officer, Mr. Gonzalez entered into an employment agreement with the Company with a one-year term, pursuant to which Mr. Gonzalez will be (i) paid an annual salary of $100,000, which may be paid by the issuance of shares of the Company's Series A Preferred Stock, and (ii) issued $50,000 of shares of the Company's Series A Preferred Stock.


The Company also entered into a Resignation and Settlement Agreement with Messrs. Gonzalez, Watson and Loewen under which all prior agreements between each of them and the Company were terminated, and under which:


(i) The Company will pay Mr. Gonzalez $250,000 on or prior to August 29, 2024 to satisfy accrued obligations owed to him in the aggregate amount of $492,777, consisting primarily of unpaid wages. In the event the Company fails to pay the settlement amount when due, such amount will increase by 200% and begin to accrue interest at the rate of 10% per annum. 


(ii) The Company will issue Mr. Watson $125,150 of shares of the Company's Series A Preferred Stock to satisfy accrued obligations owed to him in amount of $250,290 for unpaid wages. The Company has agreed to repurchase the shares of Series A Preferred Stock by August 29, 2024. In the event of a default by the Company to Mr. Watson, the settlement amount will increase by 200% and begin to accrue interest at the rate of 10% per annum. 


(iii) The Company will pay Mr. Loewen $3,140 on or prior to March 1, 2023 to satisfy unpaid consulting fees owed to him in the amount of $53,140. In the event the Company fails to pay the settlement amount when due, such amount will increase by 200% and begin to accrue interest at the rate of 10% per annum. 


Appointment of William “Joe” Reed 


On September 7, 2022, the Board of Directors of the Company appointed William J. Reed to serve as the Chairman of the Board of the Company and as its Chief Executive Officer, President and Secretary.


Mr. Reed, 44, previously served as the Chief Operating Officer of Gold Mountain Distribution, a logistics management solution for the cannabis industry, since March 2018. Mr. Reed also founded the Cali Care Group in 2010 and continues to serve as its principal owner and officer.


In connection with his appointment as Chairman and Chief Executive Officer, Mr. Reed entered into an employment agreement with the Company with a one-year term, pursuant to which Mr. Reed will be paid an annual salary of $200,000, which may be paid by the issuance of shares of the Company's Series A Preferred Stock, and issued $150,000 of shares of the Company's Series A Preferred Stock.


Other than as set forth above, there are no arrangements or understandings with Mr. Reed pursuant to which he was appointed as an officer director of the Company, and there are no related party transactions between the Company and Mr. Reed that are subject to disclosure under Item 404(a) of Regulation S-K.